Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Trained innate immunity and atherosclerosis.

Bekkering S, Joosten LA, van der Meer JW, Netea MG, Riksen NP.

Curr Opin Lipidol. 2013 Dec;24(6):487-92. doi: 10.1097/MOL.0000000000000023. Review.

PMID:
24184939
2.

The epigenetic memory of monocytes and macrophages as a novel drug target in atherosclerosis.

Bekkering S, Joosten LA, van der Meer JW, Netea MG, Riksen NP.

Clin Ther. 2015 Apr 1;37(4):914-23. doi: 10.1016/j.clinthera.2015.01.008. Epub 2015 Feb 20. Review.

PMID:
25704108
3.

Training innate immunity: the changing concept of immunological memory in innate host defence.

Netea MG.

Eur J Clin Invest. 2013 Aug;43(8):881-4. doi: 10.1111/eci.12132. Review.

PMID:
23869409
4.

Trained immunity: A smart way to enhance innate immune defence.

van der Meer JW, Joosten LA, Riksen N, Netea MG.

Mol Immunol. 2015 Nov;68(1):40-4. doi: 10.1016/j.molimm.2015.06.019. Review.

PMID:
26597205
5.

'Trained immunity': consequences for lymphoid malignancies.

Stevens WB, Netea MG, Kater AP, van der Velden WJ.

Haematologica. 2016 Dec;101(12):1460-1468. Epub 2016 Nov 10. Review.

6.

Vascular cells contribute to atherosclerosis by cytokine- and innate-immunity-related inflammatory mechanisms.

Loppnow H, Werdan K, Buerke M.

Innate Immun. 2008 Apr;14(2):63-87. doi: 10.1177/1753425908091246. Review.

PMID:
18713724
7.

Innate immune cell activation and epigenetic remodeling in symptomatic and asymptomatic atherosclerosis in humans in vivo.

Bekkering S, van den Munckhof I, Nielen T, Lamfers E, Dinarello C, Rutten J, de Graaf J, Joosten LA, Netea MG, Gomes ME, Riksen NP.

Atherosclerosis. 2016 Nov;254:228-236. doi: 10.1016/j.atherosclerosis.2016.10.019. Epub 2016 Oct 12.

8.

Long-term activation of the innate immune system in atherosclerosis.

Christ A, Bekkering S, Latz E, Riksen NP.

Semin Immunol. 2016 Aug;28(4):384-93. doi: 10.1016/j.smim.2016.04.004. Epub 2016 Apr 22. Review.

9.

Diabetes propels the risk for cardiovascular disease: sweet monocytes becoming aggressive?

van Diepen JA, Thiem K, Stienstra R, Riksen NP, Tack CJ, Netea MG.

Cell Mol Life Sci. 2016 Dec;73(24):4675-4684. Epub 2016 Jul 28. Review.

10.

Innate immunity, macrophage activation, and atherosclerosis.

Yan ZQ, Hansson GK.

Immunol Rev. 2007 Oct;219:187-203. Review.

PMID:
17850490
11.

Toll-like receptors and macrophage activation in atherosclerosis.

Seneviratne AN, Sivagurunathan B, Monaco C.

Clin Chim Acta. 2012 Jan 18;413(1-2):3-14. doi: 10.1016/j.cca.2011.08.021. Epub 2011 Aug 22. Review.

PMID:
21884686
12.

Danger signaling in atherosclerosis.

Zimmer S, Grebe A, Latz E.

Circ Res. 2015 Jan 16;116(2):323-40. doi: 10.1161/CIRCRESAHA.116.301135. Review.

13.

Vitamin A induces inhibitory histone methylation modifications and down-regulates trained immunity in human monocytes.

Arts RJ, Blok BA, van Crevel R, Joosten LA, Aaby P, Benn CS, Netea MG.

J Leukoc Biol. 2015 Jul;98(1):129-36. doi: 10.1189/jlb.6AB0914-416R. Epub 2015 May 1.

14.

Dendritic cells in atherosclerosis.

Cartland SP, Jessup W.

Curr Pharm Des. 2013;19(33):5883-90. Review.

PMID:
23438964
15.

Macrophage activation and polarization as an adaptive component of innate immunity.

Locati M, Mantovani A, Sica A.

Adv Immunol. 2013;120:163-84. doi: 10.1016/B978-0-12-417028-5.00006-5. Review.

PMID:
24070384
16.

Inflammation in atherosclerosis: transition from theory to practice.

Libby P, Okamoto Y, Rocha VZ, Folco E.

Circ J. 2010 Feb;74(2):213-20. Epub 2010 Jan 9. Review.

17.

STAT1 as a novel therapeutical target in pro-atherogenic signal integration of IFNγ, TLR4 and IL-6 in vascular disease.

Sikorski K, Czerwoniec A, Bujnicki JM, Wesoly J, Bluyssen HA.

Cytokine Growth Factor Rev. 2011 Aug;22(4):211-9. doi: 10.1016/j.cytogfr.2011.06.003. Epub 2011 Jul 12. Review.

PMID:
21752694
18.

Innate Immune Memory: The Latest Frontier of Adjuvanticity.

Töpfer E, Boraschi D, Italiani P.

J Immunol Res. 2015;2015:478408. doi: 10.1155/2015/478408. Epub 2015 Aug 25. Review.

19.

Novel monocyte biomarkers of atherogenic conditions.

Gratchev A, Ovsiy I, Manousaridis I, Riabov V, Orekhov A, Kzhyshkowska J.

Curr Pharm Des. 2013;19(33):5859-64. Review.

PMID:
23438959
20.

Innate and adaptive immunity in the pathogenesis of atherosclerosis.

Hansson GK, Libby P, Schönbeck U, Yan ZQ.

Circ Res. 2002 Aug 23;91(4):281-91. Review.

Supplemental Content

Support Center